In 2008 the FDA cleared TMS as a safe and effective treatment for Major Depressive Disorder. At River City TMS we use NeuroStar, the first device to receive FDA clearance and with the largest clinical data set of any TMS system for depression.
TMS treatment should not be painful. You may feel some local discomfort at the start of treatment, but our patients often report this sensation fading with each successive treatment. If you experience sharp pain (e.g., nerve pain, tooth ache, etc.) during treatment, please let us know and we can follow a set of protocols developed by NeuroStar to prevent discomfort.
Only NeuroStar has the world’s largest depression outcomes registry. In a study released in 2020, Sackeim et al. found that of patients who received a full course of treatment with the NeuroStar device: 83% experienced marked improvement in depressive symptoms, and 62% experienced full remission.1
- Neurostar TMS: Proven Results with Data to Prove It
- Leading TMS Treatment for Major Depressive Disorder, and an adjunct therapy for OCD and Anxious Depression
- Proven Depression Relief That Lasts.
- The #1 Physician Recommended TMS treatment. Over 5.6 million treatments have been delivered and over 156,000 patients treated
- Largest Set of Clinical Backing Neurostar’s Efficacy and Safety
- High Remission and Response Rate and a Leader in the TMS Therapy Market
- Patented Delivery Process that Optimizes the Treatment Process-from Measuring the Most Appropriate Dose (MT Assist) to Ensuring Consistent and Repeatable Pulse Delivery (Contact Sensing)
- Sackeim HA, Aaronson ST, Carpenter LL, et al. Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. J Affect Disord. 2020;277:65-74. doi:10.1016/j.jad.2020.08.005
Click to view NeuroStar’s Patient Brochure
NeuroStar Indication Statement
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy system is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.